Evidence map›Paper›PMID 36147256›Full record

ArticleJournal of diabetes research2022

The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model.

Denisa Miklankova, Irena Markova, Martina Hüttl, Barbora Stankova, Hana Malinska

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Anti-Aging Potential of Avocado Oil via Its Antioxidant Effects.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Denisa MiklankovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-8771-9338
Irena MarkovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-4331-7636
Martina HüttlCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-2484-3630
Barbora StankovaFirst Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-6184-4878
Hana MalinskaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.ORCID https://orcid.org/0000-0002-9076-3399
Institute of Clinical and Experimental Medicine · CZCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results: Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated Conclusions: Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.

Indexed as

Diabetes Mellitus, Type 2Insulin ResistancePrediabetic StateAdiponectinAnimalsAnti-Inflammatory AgentsArachidonic AcidsCytokinesFatty AcidsFatty Acids, MonounsaturatedFatty Acids, NonesterifiedGlucagonGlucoseInflammationInsulinLipoprotein LipaseAdiponectinAnti-Inflammatory AgentsArachidonic AcidsCytokinesFatty AcidsFatty Acids, MonounsaturatedFatty Acids, NonesterifiedGlucagonGlucoseInsulinLipoprotein LipaseOleic Acidpalmitoleic acid

Identifiers

PMID36147256
PMCPMC9489414
OpenAlexW4295837596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.